BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagy M, Lynch M, Kamal S, Mohamed S, Hadad A, Abouelnaga S, Aquilante CL. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt. Per Med 2020;17:251-60. [PMID: 32589096 DOI: 10.2217/pme-2019-0163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Naimat F, Fahrni ML, Purushothaman S, Abdul Ghani MN, Chumnumwat S, Babar Z. Community pharmacists’ perceived value on precision medicine, desired training components, and exposure during pharmacy education: Malaysia’s experience. Front Pharmacol 2022;13:978141. [DOI: 10.3389/fphar.2022.978141] [Reference Citation Analysis]
2 Pop C, Cristina A, Iaru I, Popa SL, Mogoșan C. Nation-Wide Survey Assessing the Knowledge and Attitudes of Romanian Pharmacists Concerning Pharmacogenetics. Front Pharmacol 2022;13:952562. [DOI: 10.3389/fphar.2022.952562] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 El-attar EA, Helmy Elkaffas RM, Aglan SA, Naga IS, Nabil A, Abdallah HY. Genomics in Egypt: Current Status and Future Aspects. Front Genet 2022;13:797465. [DOI: 10.3389/fgene.2022.797465] [Reference Citation Analysis]
4 Hayashi M, Mahmoud SH, Hamdy DA. The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists. Pharmgenomics Pers Med 2022;15:409-27. [PMID: 35496350 DOI: 10.2147/PGPM.S348851] [Reference Citation Analysis]
5 Martin JL, Lee YM, Corbin LW, Colson R, Aquilante CL. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service. Pharmacogenomics 2022. [PMID: 35469451 DOI: 10.2217/pgs-2022-0013] [Reference Citation Analysis]
6 Koufaki MI, Siamoglou S, Patrinos GP, Vasileiou K. Examining key factors impact on health science students' intentions to adopt genetic and pharmacogenomics testing: a comparative path analysis in two different healthcare settings. Hum Genomics 2022;16:9. [PMID: 35287732 DOI: 10.1186/s40246-022-00382-3] [Reference Citation Analysis]
7 Jarrar Y, Lee S. Demand for Pharmacogenomics and Personalized Medicine in the United Arab Emirates. JPM 2022;12:104. [DOI: 10.3390/jpm12010104] [Reference Citation Analysis]
8 Rahma AT, Elbarazi I, Ali BR, Patrinos GP, Ahmed LA, Elsheik M, Al-Maskari F. Development of the pharmacogenomics and genomics literacy framework for pharmacists. Hum Genomics 2021;15:62. [PMID: 34656176 DOI: 10.1186/s40246-021-00361-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Koufaki MI, Karamperis K, Vitsa P, Vasileiou K, Patrinos GP, Mitropoulou C. Adoption of Pharmacogenomic Testing: A Marketing Perspective. Front Pharmacol 2021;12:724311. [PMID: 34603034 DOI: 10.3389/fphar.2021.724311] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Albitar L, Alchamat GA. Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians. BMC Health Serv Res 2021;21:1031. [PMID: 34592972 DOI: 10.1186/s12913-021-07040-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Hayashi M, Hamdy DA, Mahmoud SH. Applications for pharmacogenomics in pharmacy practice: A scoping review. Res Social Adm Pharm 2021:S1551-7411(21)00313-2. [PMID: 34474980 DOI: 10.1016/j.sapharm.2021.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
12 McCarthy J, Patrinos G, Ginsburg G. Welcome to the 18th volume of Personalized Medicine. Per Med 2021;18:1-3. [PMID: 33459576 DOI: 10.2217/pme-2020-0176] [Reference Citation Analysis]
13 Mathuba B, Koromina M, Mitropoulou C, Patrinos GP. Catalyzing clinical implementation of pharmacogenomics and personalized medicine interventions in Africa. Pharmacogenomics 2021;22:115-22. [PMID: 33353428 DOI: 10.2217/pgs-2020-0101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Rahma AT, Elsheik M, Ali BR, Elbarazi I, Patrinos GP, Ahmed LA, Al Maskari F. Knowledge, Attitudes, and Perceived Barriers toward Genetic Testing and Pharmacogenomics among Healthcare Workers in the United Arab Emirates: A Cross-Sectional Study. J Pers Med 2020;10:E216. [PMID: 33182317 DOI: 10.3390/jpm10040216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Nagy M, Attya M, Patrinos GP. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies. Pharmacogenomics 2020;21:1247-64. [PMID: 33124490 DOI: 10.2217/pgs-2020-0056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nagy M, Tsermpini EE, Siamoglou S, Patrinos GP. Evaluating the current level of pharmacists' pharmacogenomics knowledge and its impact on pharmacogenomics implementation. Pharmacogenomics 2020;21:1179-89. [PMID: 33118449 DOI: 10.2217/pgs-2020-0076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Rahma AT, Elbarazi I, Ali BR, Patrinos GP, Ahmed LA, Al Maskari F. Genomics and Pharmacogenomics Knowledge, Attitude and Practice of Pharmacists Working in United Arab Emirates: Findings from Focus Group Discussions-A Qualitative Study. J Pers Med 2020;10:E134. [PMID: 32962013 DOI: 10.3390/jpm10030134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]